Table of Contents Author Guidelines Submit a Manuscript
Developmental Immunology
Volume 6 (1998), Issue 3-4, Pages 187-196
http://dx.doi.org/10.1155/1998/18679

CD40 Ligand and Autoantigen Are Involved in the Pathogenesis of Low-Grade B-Cell Lymphomas of Mucosa-Associated Lymphoid Tissue

1Institute of Pathology, University of Würzburg, Germany
2Robert-Koch-Institut, Berlin, Germany
3Institut für Pathologie der Univerisitãt Würzburg, Josef-Schneider str. 2, Würzburg 97080, Germany

Received 12 October 1996

Copyright © 1998 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [17 citations]

The following is the list of published articles that have cited the current article.

  • Constanze Knörr, Christa Amrehn, Harald Seeberger, Andreas Rosenwald, Stephan Stilgenbauer, German Ott, Hans-Konrad Müller Hermelink, and Axel Greiner, “Expression of Costimulatory Molecules in Low-Grade Mucosa-Associated Lymphoid Tissue-Type Lymphomas in Vivo,” The American Journal of Pathology, vol. 155, no. 6, pp. 2019–2027, 1999. View at Publisher · View at Google Scholar
  • F Riechert, S Stingl, M Neumann, Hk Muller-Hermelink, S Wassink, A Marx, and A Greiner, “Characterization of Wue-1, a novel monoclonal antibody that stimulates the growth of plasmacytoma cell lines,” Virchows Archiv, vol. 437, no. 4, pp. 372–379, 2000. View at Publisher · View at Google Scholar
  • Harald Seeberger, Petr Starostik, Stephan Schwarz, Constanze Knörr, Jörg Kalla, German Ott, Hans Konrad Müller-Hermelink, and Axel Greiner, “Loss of Fas (CD95/APO-1) Regulatory Function Is an Important Step in Early MALT-Type Lymphoma Development,” Laboratory Investigation, vol. 81, no. 7, pp. 977–986, 2001. View at Publisher · View at Google Scholar
  • C Knorr, H Seeberger, Hk Muller-Hermelink, and A Greiner, “Impaired CD95 (Fas, APO-1)-mediated apoptosis is a progression factor of early MALT-type lymphomagenesis,” Medizinische Klinik, vol. 96, no. 1, pp. 9–14, 2001. View at Publisher · View at Google Scholar
  • Anas Younes, and Marshall E. Kadin, “Emerging Applications of the Tumor Necrosis Factor Family of Ligands and Receptors in Cancer Therapy,” Journal of Clinical Oncology, vol. 21, no. 18, pp. 3526–3534, 2003. View at Publisher · View at Google Scholar
  • H Seeberger, C Knorr, C Mainhardt, Hk Muller-Hermelink, and A Greiner, “Tumor-infiltrating T cells with similar antigen binding sites in different mucosa-associated lymphoid tissue type B cell lymphomas,” Virchows Archiv, vol. 442, no. 4, pp. 343–348, 2003. View at Publisher · View at Google Scholar
  • R Yamasaki, K Yokota, H Okada, S Hayashi, M Mizuno, T Yoshino, Y Hirai, D Saitou, T Akagi, and K Oguma, “Immune response in Helicobacter pylori-induced low-grade gastric-mucosa-associated lymphoid tissue (MALT) lymphoma,” Journal Of Medical Microbiology, vol. 53, no. 1, pp. 21–29, 2004. View at Publisher · View at Google Scholar
  • Anne Mueller, Jani O'Rourke, Pauline Chu, Amanda Chu, Michael F. Dixon, Donna M. Bouley, Adrian Lee, and Stanley Falkow, “The Role of Antigenic Drive and Tumor-Infiltrating Accessory Cells in the Pathogenesis of Helicobacter-Induced Mucosa-Associated Lymphoid Tissue Lymphoma,” The American Journal of Pathology, vol. 167, no. 3, pp. 797–812, 2005. View at Publisher · View at Google Scholar
  • R Chappuis, P Mhawech, Lm Staudt, Re Davis, M Berczy, J Schwaller, B Conne, and L Ho, “MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells,” Blood, vol. 105, no. 7, pp. 2891–2899, 2005. View at Publisher · View at Google Scholar
  • Rj Bende, Wm Aarts, Rg Riedl, D de Jong, St Pals, and Cjm van Noesel, “Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity,” Journal Of Experimental Medicine, vol. 201, no. 8, pp. 1229–1241, 2005. View at Publisher · View at Google Scholar
  • M Nakagawa, M Seto, and Y Hosokawa, “Molecular pathogenesis of MALT lymphoma: two signaling pathways underlying the antiapoptotic effect of API2-MALT1 fusion protein,” Leukemia, vol. 20, no. 6, pp. 929–936, 2006. View at Publisher · View at Google Scholar
  • Philipp Ströbel, Wen-Yu Chuang, Sergei Chuvpilo, Andreas Zettl, Tiemo Katzenberger, Hubert Kalbacher, Peter Rieckmann, Wilfred Nix, Berthold Schalke, Ralf Gold, Hans-Konrad Müller-Hermelink, Pärt Peterson, and Alexander Marx, “ Common Cellular and Diverse Genetic Basis of Thymoma-associated Myasthenia Gravis ,” Annals of the New York Academy of Sciences, vol. 1132, no. 1, pp. 143–156, 2008. View at Publisher · View at Google Scholar
  • V. J. Craig, I. Arnold, C. Gerke, M. Q. Huynh, T. Wundisch, A. Neubauer, C. Renner, S. Falkow, and A. Muller, “Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins,” Blood, vol. 115, no. 3, pp. 581–591, 2009. View at Publisher · View at Google Scholar
  • Elizabeth F. Redente, David M. Higgins, Lori D. Dwyer-Nield, Ian M. Orme, Mercedes Gonzalez-Juarrero, and Alvin M. Malkinson, “Differential polarization of alveolar macrophages and bone marrow-derived monocytes following chemically and pathogen-induced chronic lung inflammation,” Journal Of Leukocyte Biology, vol. 88, no. 1, pp. 159–168, 2010. View at Publisher · View at Google Scholar
  • V J Craig, S B Cogliatti, I Arnold, C Gerke, J-E Balandat, T Wündisch, and A Müller, “B-cell receptor signaling and CD40 ligand-independent T cell help cooperate in Helicobacter-induced MALT lymphomagenesis,” Leukemia, vol. 24, no. 6, pp. 1186–1196, 2010. View at Publisher · View at Google Scholar
  • Ariel Orbach, Jacob Rachmilewitz, Noam Shani, Yonatan Isenberg, Miriam Parnas, Jui-Han Huang, Mark L. Tykocinski, and Michal Dranitzki-Elhalel, “CD40·FasL and CTLA-4·FasL Fusion Proteins Induce Apoptosis in Malignant Cell Lines by Dual Signaling,” The American Journal of Pathology, vol. 177, no. 6, pp. 3159–3168, 2010. View at Publisher · View at Google Scholar
  • E. Zucca, and F. Bertoni, “The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance,” Blood, vol. 127, no. 17, pp. 2082–2092, 2016. View at Publisher · View at Google Scholar